Office of the President
Laboratory of Brain Development and Repair
Marc Tessier-Lavigne was elected tenth president of The Rockefeller University by its Board of Trustees on September 8, 2010, following an international search. He began on March 16, 2011.
A world leader in the study of brain development, Marc has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. The mechanisms he has identified are important for understanding how the human brain forms during normal development, and are increasingly being implicated in a variety of other processes, including vascular patterning and axonal regeneration following spinal cord injury, as well as neurodegeneration such as that seen in Alzheimer's disease.
A native of Trenton, Canada, Marc obtained his Ph.D. from University College London and performed postdoctoral work at the MRC Developmental Neurobiology Unit in London and at Columbia University. He has been on the faculty of the University of California, San Francisco and Stanford University and has been a Howard Hughes Medical Institute investigator. In 2003, Marc joined Genentech, one of the worldís leading biotech companies, where he oversaw 1,400 people in disease research and drug discovery as executive vice president and chief scientific officer.
He is the recipient of numerous scientific awards and is an elected member of the U.S. National Academy of Sciences and a fellow of the Royal Societies of the U.K. and Canada.
On February 4, 2016, it was announced that Marc Tessier-Lavigne will step down from his position, effective September 1, 2016, to become the 11th president of Stanford University.
In the News
New Stanford President Has Biotech Connection
The New York Times, February 5, 2016
Conversations in the Digital Age
CUNY Television, January 11, 2016
Major Donations Bolster Hospital, Medical Research
Wall Street Journal, May 20, 2015
Rockefeller U. bags $150M for expansion
Crain's New York Business, November 25, 2014
Wanted: Biotech Startups in New York City
Wall Street Journal, July 8, 2014
Speeches and Writings
City should invest in its potential as a life-science hub
Crain's New York Business, December 15, 2013